Intermittent Fasting Shows Promise for Type 1 Diabetes Management in Small Trial
A new randomized trial has investigated the effects of time-restricted eating, a form of intermittent fasting, in adults with type 1 diabetes who are also overweight or obese. The study, which involved 32 participants, assigned individuals to one of three groups for six months: an eight-hour eating window (noon to 8 p.m.) without calorie counting, a daily 25% calorie reduction, or no dietary intervention. The findings indicated that the time-restricted eating group experienced an improvement in HbA1c levels compared to the calorie-restriction group, specifically a reduction of approximately 0.46 percentage points. Crucially, this group did not report an increase in severe hypoglycemia, hyperglycemia, or diabetic ketoacidosis, which are significant safety concerns for individuals managing type 1 diabetes. While the study suggests potential benefits for glucose control, researchers emphasize that this was a small, supervised trial and does not constitute a recommendation for individuals with type 1 diabetes ...